Tetratherix (TTX) Short Interest
Tetratherix (ASX:TTX) had 0.00% of shares reported as short positions as of 31 Aug 2026, representing 54 shares. Tetratherix operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Tetratherix
Short position
Tetratherix (ASX:TTX) has 0.00% of its shares on issue reported as short positions as of 31 Aug 2026, or about 54 shares. TTX is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 36, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4TTX intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Latest TTX news
All news- Tetratherix Ships First US Polymer, Revenue Begins
asx · 30 Aug 2026
- Application for quotation of securities - TTX
asx · 23 Aug 2026
- Results Presentation 2026
asx · 19 Aug 2026
- Appendix 4E and Annual Report 2026
asx · 19 Aug 2026
- Is Tetratherix (ASX:TTX) Emerging as a Healthcare Technology Stock to Watch? - Kalkine
googlenews · 7 Aug 2026
About
Company information is being updated. Check back soon.
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss TTX
Start a research thread or post the first pulse update